Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-24-121722

Director sold 5,000 shares at an average $300.94 ($1,504,703)

  • Director acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Levy Richard S Director 2024-11-01 Option exercise 10b5-1 +5,000 $7.36 $36,800 16,012 D
Levy Richard S Director 2024-11-01 Sale 10b5-1 −2,800 $300.10 $840,278 13,212 D
Levy Richard S Director 2024-11-01 Sale 10b5-1 −1,100 $301.22 $331,339 12,112 D
Levy Richard S Director 2024-11-01 Sale 10b5-1 −800 $302.25 $241,799 11,312 D
Levy Richard S Director 2024-11-01 Sale 10b5-1 −300 $304.29 $91,287 11,012 D
Derivatives
Levy Richard S Director 2024-11-01 Option exercise · Stock Option (Right to Buy) 10b5-1 −5,000 10,000 D
Open-market sales · 5,000 sh · avg $300.94 · $1,504,703
Loading xslF345X05/ownership.xml…